The Claim
Individuals with coronary artery disease have significantly lower serum levels of glucagon-like peptide-1 (GLP-1) than individuals without coronary artery disease.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
People with coronary artery disease have lower levels of the hormone glucagon-like peptide-1 in their blood than people without coronary artery disease.
See the scientific wording
Serum levels of glucagon-like peptide-1 (GLP-1) are significantly lower in individuals with coronary artery disease compared to those without, suggesting a potential protective role for this hormone in cardiovascular health.
An imbalance in gut bacteria reduces the production of a hormone that protects blood vessels. Without this hormone, blood vessels cannot relax properly, inflammation increases, and plaque builds up in the arteries.
What the research says
1 studyPeople with heart disease had less of a helpful hormone called GLP-1 in their blood than people without heart disease, suggesting this hormone might help protect the heart.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.